As previously published, MACC1 (32) and ADPRH (33) ABCG2 (34), and ANG (35) correlate with glioma cell proliferation, invasion, immune infiltration, drug efficacy, and worse prognosis in glioma patients. The gene discussed is MACC1; the disease is central nervous system cancer.